Cargando…
Inequities in the Geographic Accessibility of COVID-19 Biomedical Therapeutic Trials in the United States
Autores principales: | Khazanchi, Rohan, Powers, Samuel D., Rogawski McQuade, Elizabeth T., McManus, Kathleen A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415187/ https://www.ncbi.nlm.nih.gov/pubmed/34480335 http://dx.doi.org/10.1007/s11606-021-07081-0 |
Ejemplares similares
-
Geographic Variation in Qualified Health Plan Coverage and Prior Authorization Requirements for HIV Preexposure Prophylaxis
por: McManus, Kathleen A., et al.
Publicado: (2023) -
Regional Disparities in Qualified Health Plans’ Prior Authorization Requirements for HIV Pre-exposure Prophylaxis in the United States
por: McManus, Kathleen A., et al.
Publicado: (2020) -
Geographic Accessibility of COVID-19 Test to Treat Sites by Race, Ethnicity, Age, and Rurality
por: Khazanchi, Rohan, et al.
Publicado: (2022) -
Medicaid Expansion’s Impact on Human Immunodeficiency Virus Outcomes in a Nonurban Southeastern Ryan White HIV/AIDS Program Clinic
por: McManus, Kathleen A, et al.
Publicado: (2020) -
Worsening Disparities in State-Level Uptake of Human Immunodeficiency Virus Preexposure Prophylaxis, 2014–2018
por: Powers, Samuel D, et al.
Publicado: (2021)